Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 15;9(5):79-90.
doi: 10.5501/wjv.v9.i5.79.

Reinfection risk of novel coronavirus (COVID-19): A systematic ‎review of current evidence

SeyedAhmad SeyedAlinaghi  1 , Shahram Oliaei  2 , Shaghayegh Kianzad  3 , Amir Masoud Afsahi  4 , Mehrzad MohsseniPour  1 , Alireza Barzegary  5 , Pegah Mirzapour  1 , Farzane Behnezhad  6 , Tayebeh Noori  7 , Esmaeil Mehraeen  8 , Omid Dadras  9 , Fabricio Voltarelli  10 , Jean-Marc Sabatier  11
Affiliations

Reinfection risk of novel coronavirus (COVID-19): A systematic ‎review of current evidence

SeyedAhmad SeyedAlinaghi et al. World J Virol. .

Abstract

Background: There is recently a concern regarding the reinfection and reactivation of previously reCoVered coronavirus disease 2019 (CoVID-19) patients.

Aim: To summarize the recent findings and reports of CoVID-19 reinfection in patients previously reCoVered from the disease.

Methods: This study was a systematic review of current evidence conducted in August 2020. The authors studied the probable reinfection risk of novel coronavirus (CoVID-19). We performed a systematic search using the keywords in online databases. The investigation adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist to ensure the reliability and validity of this study and results.

Results: We reviewed 31 studies. Eight studies described reCoVered patients with reinfection. Only one study reported reinfected patients who died. In 26 studies, there was no information about the status of the patients. Several studies indicated that reinfection is not probable and that post-infection immunity is at least temporary and short.

Conclusion: Based on our review, we concluded that a positive polymerase chain reaction retest could be due to several reasons and should not always be considered as reinfection or reactivation of the disease. Most relevant studies in positive retest patients have shown relative and probably temporary immunity after the reCoVery of the disease.

Keywords: CoVID-19; Coronavirus; Postinfection; Reactivation; Reinfection; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors confirm that they have no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram for the selection process of identified articles.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
    Haq M, Rehman A, Ahmad J, Zafar U, Ahmed S, Khan MA, Naveed A, Rajab H, Muhammad F, Naushad W, Aman M, Rehman HU, Ahmad S, Anwar S, Haq NU. Haq M, et al. Infection. 2021 Oct;49(5):983-988. doi: 10.1007/s15010-021-01629-2. Epub 2021 May 25. Infection. 2021. PMID: 34032997 Free PMC article. Clinical Trial.
  • Fatal outcome subsequent to reoccurring SARS-CoV2 infection in a kidney transplant recipient.
    Kute VB, Meshram HS, Patel HV, Engineer D, Chauhan S, Banerjee S, Navadiya VV, Desai S, Patel AH, Deshumkh S, Dave R, Mishra VV. Kute VB, et al. Clin Transplant. 2021 Sep;35(9):e14383. doi: 10.1111/ctr.14383. Epub 2021 Jul 4. Clin Transplant. 2021. PMID: 34101891 Free PMC article. No abstract available.
  • COVID-19: Is reinfection possible?
    Costa AOC, de Carvalho Aragão Neto H, Lopes Nunes AP, Dias de Castro R, Nóbrega de Almeida R. Costa AOC, et al. EXCLI J. 2021 Mar 2;20:522-536. doi: 10.17179/excli2021-3383. eCollection 2021. EXCLI J. 2021. PMID: 33883981 Free PMC article. Review.
  • Suspected COVID-19 Reinfections at a Tertiary Care Center, Iowa, 2020.
    Kobayashi T, Ortiz ME, Imborek KL, Alsuhaibani M, Holley SA, Trannel A, Marra AR, Etienne W, Jenn KE, Abosi OJ, Meacham H, Sheeler LL, Dains A, Kukla ME, McCray PB Jr, Perlman S, Ford B, Diekema DJ, Wellington M, Salinas JL, Pezzulo AA. Kobayashi T, et al. Open Forum Infect Dis. 2021 Apr 14;8(7):ofab188. doi: 10.1093/ofid/ofab188. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34322564 Free PMC article. No abstract available.
  • The clinical outcomes of COVID-19 in HIV-positive patients: A systematic review of current evidence.
    SeyedAlinaghi S, Karimi A, MohsseniPour M, Barzegary A, Mirghaderi SP, Fakhfouri A, Saeidi S, Razi A, Mojdeganlou H, Tantuoyir MM, Afsahi AM, Mehraeen E, Dadras O. SeyedAlinaghi S, et al. Immun Inflamm Dis. 2021 Dec;9(4):1160-1185. doi: 10.1002/iid3.497. Epub 2021 Jul 29. Immun Inflamm Dis. 2021. PMID: 34324280 Free PMC article.
See all "Cited by" articles

References

    1. Sekhavati E, Jafari F, SeyedAlinaghi S, Jamalimoghadamsiahkali S, Sadr S, Tabarestani M, Pirhayati M, Zendehdel A, Manafi N, Hajiabdolbaghi M, Ahmadinejad Z, Kouchak HE, Jafari S, Khalili H, Salehi M, Seifi A, Golestan FS, Ghiasvand F. Safety and effectiveness of azithromycin in patients with CoVID-19: An open-label randomised trial. Int J Antimicrob Agents. 2020;56:106143. - PMC - PubMed
    1. Ye G, Pan Z, Pan Y, Deng Q, Chen L, Li J, Li Y, Wang X. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020;80:e14–e17. - PMC - PubMed
    1. Mehraeen E, Behnezhad F, Salehi MA, Noori T, Harandi H, SeyedAlinaghi S. Olfactory and gustatory dysfunctions due to the coronavirus disease (CoVID-19): a review of current evidence. Eur Arch Otorhinolaryngol. 2020;17:1–6. - PMC - PubMed
    1. SeyedAlinaghi S, Ghadimi M, Hajiabdolbaghi M, Rasoolinejad M, Abbasian L, Nezhad MH, Manshadi SD, Ghadimi F, Ahmadinejad Z. Prevalence of CoVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment. Curr HIV Res. 2020;18:373–380. - PubMed
    1. ‎ Zhao W, Wang Y, Tang Y, Zhao W, Fan Y, Liu G, Chen R, Song R, Zhou W, Liu Y, Zhang F. Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge. Clin ‎Pediatr (Phila) 2020;59:929–932. - PubMed